Evidence map›Paper›PMID 37769134›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2023

[Renoprotection. About World Kidney Day].

Antonio Méndez-Durán, Célida Duque-Molina, Roberto Teva-Luna, Ricardo Avilés-Hernández

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. [Brown tumor due to hyperparathyroidism secondary to chronic kidney disease: A clinical case].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antonio Méndez-DuránInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Unidad de Planeación e Innovación en Salud. Ciudad de México, México.ORCID 0000-0002-2596-4581
Célida Duque-MolinaInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas. Ciudad de México, México.ORCID 0000-0002-8252-3205
Roberto Teva-LunaInstituto Mexicano del Seguro Social, Coordinación de Atención Integral de Segundo Nivel, División de Hospitales de Segundo Nivel. Ciudad de México, México.ORCID 0000-0002-9010-6970
Ricardo Avilés-HernándezInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Unidad de Planeación e Innovación en Salud. Ciudad de México, México.ORCID 0000-0001-8280-4931
Mexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Kidney Day was founded in 2003 by doctor Joel D. Kopple, American nephrologist, who in the session in the Congress of the International Federation of Kidney Foundations explained the need to implement the celebration on a day that alludes to this organ, in order to direct preventive actions for kidney disease and raise awareness in the medical community and the general population on the importance of caring for the kidneys. 3 years later, the proposal was accepted and as of 2006 World Kidney Day is celebrated. The diffusion is found throughout the world and in each place there are talks, courses, workshops, cultural activities and even marathons related to the prevention, diagnosis and treatment of kidney disease. Chronic kidney disease (CKD) is a disorder with a chronic, degenerative, and lethal evolution. Managing CKD requires a large amount of human, financial, and infrastructure resources. It impairs the quality of life and negatively affects survival. On the other hand, it leads to dialysis and kidney transplant treatments, which are expensive enough to put any health institution at financial risk, especially those most vulnerable. The main idea of these non-profit international organizations is to promote the well-being and improve the quality of life of people with CKD with and without dialysis, and to promote kidney transplantation as the first treatment option.

Indexed as

Kidney TransplantationRenal Insufficiency, ChronicHumansKidneyQuality of LifeRenal DialysisChronic Kidney DiseasePrevalenceRisk Factors

Identifiers

PMID37769134
PMCPMC10599775
OpenAlexW4387075137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.